Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
<p>The experimental malaria vaccine ChAd63 MVA ME-TRAP previously showed protective efficacy against Plasmodium falciparum infection in Phase IIa sporozoite challenge studies in adults in the United Kingdom and in a Phase IIb field efficacy trial in Kenyan adults. However, it failed to demonst...
मुख्य लेखकों: | Morter, R, Tiono, AB, Nébié, I, Hague, O, Ewer, K, Sirima, SB |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Frontiers Media
2022
|
समान संसाधन
-
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
द्वारा: Richard Morter, और अन्य
प्रकाशित: (2022-12-01) -
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
द्वारा: Tiono, AB, और अन्य
प्रकाशित: (2018) -
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
द्वारा: Alfred B Tiono, और अन्य
प्रकाशित: (2018-01-01) -
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants
द्वारा: Bliss, C, और अन्य
प्रकाशित: (2016) -
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
द्वारा: Kimani, D, और अन्य
प्रकाशित: (2014)